Meyka Pro banner
Transcenta Holding Limited

Transcenta Holding Limited Fundamental Analysis

6628.HKHKSE
HealthcareBiotechnology
HK$1.14
HK$0.06(5.56%)
Hong Kong Market is Open · 15:53

Transcenta Holding Limited Fundamental Analysis

Transcenta Holding Limited (6628.HK) shows weak financial fundamentals with a PE ratio of -2.03, profit margin of -27.40%, and ROE of -32.08%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.06

Areas of Concern

ROE-32.08%
Operating Margin-26.99%
Cash Position2.97%
Current Ratio0.25
We analyze 6628.HK's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -2585.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-2585.5/100

We analyze 6628.HK's fundamental strength across five key dimensions:

Efficiency Score

Weak

6628.HK struggles to generate sufficient returns from assets.

ROA > 10%
-22.03%

Valuation Score

Excellent

6628.HK trades at attractive valuation levels.

PE < 25
-2.03
PEG Ratio < 2
-0.06

Growth Score

Weak

6628.HK faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

6628.HK shows balanced financial health with some risks.

Debt/Equity < 1
0.20
Current Ratio > 1
0.25

Profitability Score

Weak

6628.HK struggles to sustain strong margins.

ROE > 15%
-3207.69%
Net Margin ≥ 15%
-27.40%
Positive Free Cash Flow
No

Key Financial Metrics

Is 6628.HK Expensive or Cheap?

P/E Ratio

6628.HK trades at -2.03 times earnings. This suggests potential undervaluation.

-2.03

PEG Ratio

When adjusting for growth, 6628.HK's PEG of -0.06 indicates potential undervaluation.

-0.06

Price to Book

The market values Transcenta Holding Limited at 0.67 times its book value. This may indicate undervaluation.

0.67

EV/EBITDA

Enterprise value stands at -1.95 times EBITDA. This is generally considered low.

-1.95

How Well Does 6628.HK Make Money?

Net Profit Margin

For every $100 in sales, Transcenta Holding Limited keeps $-27.40 as profit after all expenses.

-27.40%

Operating Margin

Core operations generate -26.99 in profit for every $100 in revenue, before interest and taxes.

-26.99%

ROE

Management delivers $-32.08 in profit for every $100 of shareholder equity.

-32.08%

ROA

Transcenta Holding Limited generates $-22.03 in profit for every $100 in assets, demonstrating efficient asset deployment.

-22.03%

Following the Money - Real Cash Generation

Operating Cash Flow

Transcenta Holding Limited generates limited operating cash flow of $-137.20M, signaling weaker underlying cash strength.

$-137.20M

Free Cash Flow

Transcenta Holding Limited generates weak or negative free cash flow of $-144.58M, restricting financial flexibility.

$-144.58M

FCF Per Share

Each share generates $-0.34 in free cash annually.

$-0.34

FCF Yield

6628.HK converts -34.39% of its market value into free cash.

-34.39%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-2.03

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.06

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.67

vs 25 benchmark

P/S Ratio

Price to sales ratio

55.91

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.20

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.25

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.32

vs 25 benchmark

ROA

Return on assets percentage

-0.22

vs 25 benchmark

ROCE

Return on capital employed

-0.28

vs 25 benchmark

How 6628.HK Stacks Against Its Sector Peers

Metric6628.HK ValueSector AveragePerformance
P/E Ratio-2.0329.15 Better (Cheaper)
ROE-32.08%438.00% Weak
Net Margin-2740.08%-11409.00% (disorted) Weak
Debt/Equity0.200.78 Strong (Low Leverage)
Current Ratio0.255.14 Weak Liquidity
ROA-22.03%-21.00% (disorted) Weak

6628.HK outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Transcenta Holding Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ